Spirepoint Private Client’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.7M Sell
108,989
-430
-0.4% -$100K 2.24% 11
2026
Q1
$26.7M Buy
109,419
+2,484
+2% +$579K 2.54% 9
2025
Q4
$22.1M Buy
106,935
+3,589
+3% +$710K 2.12% 10
2025
Q3
$19.2M Buy
103,346
+2,430
+2% +$416K 2.01% 9
2025
Q2
$15.4M Buy
100,916
+89
+0.1% +$13.7K 1.74% 9
2025
Q1
$16.7M Buy
100,827
+3,711
+4% +$581K 2.18% 6
2024
Q4
$14M Buy
97,116
+2,676
+3% +$415K 1.76% 11
2024
Q3
$15.3M Buy
94,440
+1,451
+2% +$231K 2.03% 6
2024
Q2
$13.6M Sell
92,989
-5,487
-6% -$816K 1.93% 10
2024
Q1
$15.6M Buy
+98,476
New +$15.7M 2.37% 6

Other funds holding JNJ

Spirepoint Private Client's JNJ Position: Q2 2026 in Review

Spirepoint Private Client reduced its Johnson & Johnson (JNJ) stake by 0.39% in Q2 2026, selling an estimated $100K and leaving 108,989 shares worth $27.7M. The position accounts for 2.24% of the portfolio, ranked #11.

Spirepoint Private Client first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Spirepoint Private Client held 108,989 shares of Johnson & Johnson worth $27.7M as of Q2 2026.
  • Spirepoint Private Client sold 430 Johnson & Johnson shares in Q2 2026, an estimated $100K.
  • Johnson & Johnson made up 2.24% of Spirepoint Private Client's portfolio in Q2 2026, its #11 holding.
  • Spirepoint Private Client first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.